<DOC>
	<DOCNO>NCT01263717</DOCNO>
	<brief_summary>HIV-infection treatment often associated increase belly fat , well abnormal cholesterol problem metabolize sugar . People HIV infection increase belly fat often decreased growth hormone ( GH ) level . Low GH level may contribute independently increase belly fat increase cardiovascular risk effect sugar metabolism , inflammation , mechanism . Tesamorelin , growth hormone release hormone ( GHRH ) analogue , show reduce belly fat patient HIV-associated abdominal fat accumulation . However , effect tesamorelin fat accumulation liver muscle , sugar metabolism , cardiovascular health yet know . The current study design determine effect tesamorelin treatment fat accumulation muscle liver , insulin sensitivity sugar metabolism , marker cardiovascular health include blood vessel thickness ( carotid intima medium thickness [ cIMT ] ) marker inflammation body . The investigator hypothesize tesamorelin decrease fat accumulation liver muscle decrease marker inflammation , either neutral beneficial effect glucose metabolism .</brief_summary>
	<brief_title>Effects Growth Hormone Releasing Hormone HIV</brief_title>
	<detailed_description />
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Growth Hormone-Releasing Hormone</mesh_term>
	<criteria>1 . Men woman age 1865 2 . Previously diagnose HIV infection 3 . Stable antiviral regimen least 12 week prior enrollment 4 . WC &gt; 95 cm WHR &gt; 0.94 male , WC &gt; 94 cm WHR &gt; 0.88 female occur context treatment HIV disease 5 . Subjective evidence least one follow recent change , occur treatment HIV disease : increase abdominal girth , relative loss fat extremity , relative loss fat face 6 . For female subject 40yo old , negative mammogram within one year baseline 1 . Use antidiabetic agent , Megace , testosterone steroid use within 6 month study . Stable use testosterone ( &gt; 6 mo ) dose equivalent 200 mg IM q 2 week &lt; 10g/day skin permit . 2 . Use GH GHRH within past 6 month 3 . Change lipid lower antihypertensive regimen within 3 month screen 4 . Fasting blood sugar &gt; 126 mg/dL , SGOT &gt; 2.5 time ULN , HgB &lt; 12.0 g/dL , creatinine &gt; 1.4 mg/dL , CD4 count &lt; 200 5 . Severe chronic illness active malignancy history pituitary malignancy history colon cancer 6 . For men , history prostate cancer evidence prostate malignancy PSA &gt; 5 ng/mL 7 . Prior history hypopituitarism , head irradiation condition know affect GH axis 8 . For woman , positive urine hCG 9 . Oral contraceptive , depo provera combine progesteroneestrogen injection , transdermal contraceptive patch , estrogen progestin coat IUD 's within 6 month study . 10 . Routine MRI exclusion criterion presence pacemaker cerebral aneurysm clip .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>lipodystrophy</keyword>
	<keyword>tesamorelin</keyword>
	<keyword>Egrifta</keyword>
	<keyword>growth hormone release hormone</keyword>
</DOC>